Excessive Supraventricular Activity and Atrial Fibrillation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Excessive Supraventricular Activity and Atrial Fibrillation — Stella

Recruiting

Back to Atrial Fibrillation trials

Trial locations(1 site)

Sweden

Danderyd Hospital, Stockholm

Key details

Sponsor

Karolinska Institutet

Collaborators

Danderyd Hospital

Enrollment target

~250 participants

Started

November 2022

Primary completion

December 2026

Age range

70 Years – 89 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov